Biontech SE

Common Name

Biontech

Country

Germany

Sector

Healthcare

Industry

Biotechnology

Employees

6,772

Ticker

BNTX

Exchange

NASDAQ/NGS

Website

www.biontech.com

Description

BioNTech SE is a biotechnology company, represented in the financial market through American Depositary Receipts (ADRs). This setup allows American investors to own shares in BioNTech, a German-based ... Show more

Financial Statements of Biontech

Below are the financial statements of Biontech, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of EUR	2024	2023
Non-current assets	—	—
Goodwill	380.6^a	362.5^a
Other intangible assets	790.4^a	804.1^a
Property, plant and equipment	935.3^a	757.2^a
Right-of-use assets	248.1^a	214.4^a
Contract assets	9.8^a	0^a
Other financial assets	1,254^a	1,176.1^a
Other non-financial assets	26.3^a	83.4^a
Deferred tax assets	81.7^a	81.3^a
Total non-current assets	3,726.2^a	3,479^a
Current assets	—	—
Inventories	283.3^a	357.7^a
Trade and other receivables	1,463.9^a	2,155.7^a
Contract assets	10^a	4.9^a
Other financial assets	7,021.7^a	4,885.3^a
Other non-financial assets	212.7^a	280.9^a
Income tax assets	50^a	179.1^a
Cash and cash equivalents	9,761.9^a	11,663.7^a
Total current assets	18,803.5^a	19,527.3^a
Total assets	22,529.7^a	23,006.3^a
Equity	—	—
Share capital	248.6^a	248.6^a
Capital reserve	1,398.6^a	1,229.4^a
Treasury shares	-8.6^a	-10.8^a
Retained earnings	19,098^a	19,763.3^a
Other reserves	-1,325.5^a	-984.6^a
Total equity	19,411.1^a	20,245.9^a
Non-current liabilities	—	—
Lease liabilities, loans and borrowings	214.7^a	191^a
Other financial liabilities	46.9^a	38.8^a
Provisions	20.9^a	8.8^a
Contract liabilities	183^a	398.5^a
Other non-financial liabilities	87.5^a	13.1^a
Deferred tax liabilities	42.4^a	39.7^a
Total non-current liabilities	595.4^a	689.9^a
Current liabilities	—	—
Lease liabilities, loans and borrowings	39.5^a	28.1^a
Trade payables and other payables	426.7^a	354^a
Other financial liabilities	1,443.4^a	415.2^a
Income tax liabilities	4.5^a	525.5^a
Provisions	144.8^a	269.3^a
Contract liabilities	294.9^a	353.3^a
Other non-financial liabilities	169.4^a	125.1^a
Total current liabilities	2,523.2^a	2,070.5^a
Equity and liabilities	—	—
Total liabilities	3,118.6^a	2,760.4^a
Total equity and liabilities	22,529.7^a	23,006.3^a

Verified Sources Behind Biontech’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Biontech’s data sources below and access millions more through our Disclosure Search.

a. Biontech's Annual Report 2024

Trace every data point back to Biontech’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Biontech SE

Financial Statements of Biontech

Verified Sources Behind Biontech’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Gerresheimer AG

Fielmann Group AG

Fresenius Medical Care AG

Sartorius AG

SCHOTT Pharma AG & Co KgaA

Carl Zeiss Meditec AG